Mindfulness under the microscope: what it feels like for those at psychosis risk
NCT ID NCT07499934
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study interviews 20 people aged 15–30 who are at ultra-high risk for psychosis or have had a first episode. They all took part in a group mindfulness program. Researchers want to understand their personal experiences and any possible downsides, using a detailed interview method called IPSE.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help design better mindfulness programs for people at risk of psychosis, improving mental health support.
- What could go wrong
- This is a very small, early-stage qualitative study with only 20 participants. It does not test a treatment, so results may not lead to direct clinical changes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CLINICAL HIGH RISK FOR PSYCHOSIS (CHR) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre Psychothérapique de Nancy
RECRUITINGLaxou, 54520, France
-
Clinique Fondation Santé des Etudiants de France
RECRUITINGVitry-le-François, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Hope in action: peer support may curb suicide risk in youth facing psychosis
- New french test could catch psychosis warning signs earlier in teens
- Can mindfulness stop psychosis before it starts?
- CBD trial aims to stop psychosis before it starts
- Can online therapy help prevent psychosis in At-Risk youth?
- Brain games for psychosis prevention: a new hope?